AQST Earnings Aquestive Therapeutics, Inc.
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–20 of 20
| Q1 2026 | 2026-03-31 | -0.07 | 2026-05-13 | 10-Q |
| FY 2025 | 2025-12-31 | -0.78 | 2026-03-04 | 10-K |
| Q3 2025 | 2025-09-30 | -0.51 | 2025-11-05 | 10-Q |
| Q2 2025 | 2025-06-30 | -0.37 | 2025-08-11 | 10-Q |
| Q1 2026 | 2025-03-31 | -0.24 | 2026-05-13 | 10-Q |
| FY 2025 | 2024-12-31 | -0.51 | 2026-03-04 | 10-K |
| Q3 2025 | 2024-09-30 | -0.32 | 2025-11-05 | 10-Q |
| Q2 2025 | 2024-06-30 | -0.19 | 2025-08-11 | 10-Q |
| Q1 2025 | 2024-03-31 | -0.17 | 2025-05-12 | 10-Q |
| FY 2024 | 2023-12-31 | -0.13 | 2025-03-05 | 10-K |
| Q3 2024 | 2023-09-30 | 0.00 | 2024-11-04 | 10-Q |
| Q2 2024 | 2023-06-30 | 0.04 | 2024-08-06 | 10-Q |
| Q1 2024 | 2023-03-31 | 0.11 | 2024-05-07 | 10-Q |
| FY 2023 | 2022-12-31 | -1.12 | 2024-03-05 | 10-K |
| Q3 2023 | 2022-09-30 | -0.90 | 2023-11-06 | 10-Q |
| Q2 2023 | 2022-06-30 | -0.68 | 2023-08-07 | 10-Q |
| Q1 2023 | 2022-03-31 | -0.32 | 2023-05-02 | 10-Q |
| FY 2022 | 2021-12-31 | -1.85 | 2023-03-31 | 10-K |
| Q3 2022 | 2021-09-30 | -1.12 | 2022-11-01 | 10-Q |
| Q2 2022 | 2021-06-30 | -0.74 | 2022-08-02 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.